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Substantial data suggest that flavonoid-rich food could help prevent cardiovascular disease and cancer. Cocoa is 
the richest source of flavonoids, but current processing reduces the content substantially. The Kuna living in the 
San Blas drink a flavanol-rich cocoa as their main beverage, contributing more than 900 mg/day and thus 
probably have the most flavonoid-rich diet of any population. We used diagnosis on death certificates to compare 
cause-specific death rates from year 2000 to 2004 in mainland and the San Blas islands where only Kuna live. Our 
hypothesis was that if the high flavanoid intake and consequent nitric oxide system activation were important the 
result would be a reduction in the frequency of ischemic heart disease, stroke, diabetes mellitus, and cancer – all 
nitric oxide sensitive processes. There were 77,375 deaths in mainland Panama and 558 deaths in the San Blas. In 
mainland Panama, as anticipated, cardiovascular disease was the leading cause of death (83.4 ± 0.70 age adjusted 
deaths/100,000) and cancer was second (68.4 ± 1.6). In contrast, the rate of CVD and cancer among is-
land-dwelling Kuna was much lower (9.2 ± 3.1) and (4.4 ± 4.4) respectively. Similarly deaths due to diabetes 
mellitus were much more common in the mainland (24.1 ± 0.74) than in the San Blas (6.6 ± 1.94). This compara-
tively lower risk among Kuna in the San Blas from the most common causes of morbidity and mortality in much 
of the world, possibly reflects a very high flavanol intake and sustained nitric oxide synthesis activation. How-
ever, there are many risk factors and an observational study cannot provide definitive evidence. 
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1.  Introduction 
The effects of plant flavonoids on mammalian 
cells have been of substantial recent interest, with at-
tention focused on the implications of these agents for 
cardiovascular disease and for cancer [1]. Some epi-
demiological studies designed to examine a possible 
protective effect of flavonoids in cardiovascular dis-
ease have reported inverse associations [2-15]. Incon-
sistencies may be due to measurement error because 
foods that are flavanol-rich, such as grapes, red wine, 
or cocoa and chocolate shows remarkable variability in 
the flavonoid content, largely reflecting processing 
[16-18].  
The Kuna Indians of Panama are known for their 
low blood pressure levels and little rise in blood pres-
sure with age [19-21]. Our interest began with a search 
for protective genes, but the protection was environ-
mental rather than genetic [20]. As no environmental 
factor identified to date will reduce blood pressure 
levels to 110/70 mm Hg -- the average found in the 
Kuna, even those over 65 years of age -- identification 
of potential environmental factors was of considerable 
interest. We learned that Kuna still residing in their 
indigenous location in the San Blas islands drank cocoa, 
all locally grown, as their major source of fluid. The 
cocoa proved to be flavanol-rich [22]. The flavonoids 
were shown to cause the activation of nitric oxide 
synthase in healthy volunteers and patients with 
atherosclerosis [23, 24].   
The very high flavonoid intake taken by virtually 
all Kuna Indians residing in their indigenous home 
area, enjoying what is almost certainly the highest 
flavanoid intake of any community, has created an 
opportunity to examine the possible role of a sustained 
high flavonoid intake on cardiovascular disease and 
cancer -- two major contributors to morbidity and 
mortality [1]. There are also reasons for suspecting that 
flavonoids could protect against diabetes mellitus, as 
they improve sensitivity to insulin [25]. We employed 
death certificates mandated by the Republic of Panama 
for all deaths within the Republic. One cannot be bur-
ied without a completed death certificate. As only 
Kuna Indians can own land in the San Blas and all but 
a very small fraction of the residents are Kuna Indians, 
this allowed us to compare a population characterized Int. J. Med. Sci. 2007, 4 
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by a very high sustained flavonoid intake with another 
population in which flavonoid intake is more variable, 
on average much lower. Cocoa obtained in the 
mainland from grocery stores is flavanol-poor [18, 22]. 
Because there are many risk factors for each of these 
processes and because death certificates contain little 
information on risk beyond age and to avoid poten-
tially spurious evidence on risk, we prespecified that a 
significant outcome from this study would demon-
strate a lower frequency of 4 processes in the San Blas 
-- ischemic heart disease, stroke, diabetes mellitus, and 
cancer. These complex processes have little in common 
other than the possibility that flavanols might influ-
ence their development and progression [1].  
2.  Materials and methods 
Death certificates for the years 2000 to 2004 were 
available for 77,375 in mainland Panama and 548 indi-
viduals in the San Blas. A single cause of death was 
listed by either the attending physician or by a local 
health authority. Contributing causes of death were 
not listed, nor was ethnicity listed. All of the data were 
submitted to the Panamanian Ministry of Health in 
Panama City and were available for analysis. The code 
of the specific cause of death was based on the detailed 
list of the International Class of Occasional Statistics of 
Diseases and Problems Related Health Problems (CID 
9 and 10).   
The age distribution in the San Blas and in the 
Panama mainland was obtained from the most recent 
census information obtained in the year 2004.  
  Frequency of deaths per hundred thousand 
population were tabulated for various causes of death, 
both with and without age-adjustment and relative 
risk and 95 percent confidence interval were calculated. 
We used the Student’s t-test and Chi Square to com-
pare the frequency of cause-specific deaths in 
mainland Panama and the San Blas. Chi square was 
used to assess differences in age distribution across the 
two regions. We considered a p value of less than 0.05 
as statistically significant. 
3.   Results 
In mainland Panama, the most common cause of 
death was diseases of the circulation with a frequency 
of 119/100,000/year (Table 1). This was made up al-
most equally of ischemic heart disease with a fre-
quency of 43.94/100,000/year and stroke with a fre-
quency of 41.34/100,000/year. The frequency was 
somewhat greater in males, 132/100,000/year, than in 
females, 106/100,000/year, and as expected showed a 
striking increase with age, reaching a peak of 
1,193/100,000/year in those over 60 years of age. 
Cancer followed with a frequency of 
74.71/100,000/year. The frequency in males 
(77.6/100,000/yr) exceeded only slightly the frequency 
in females (71.8/100,000/yr). Again, rates peaked 
among those over 60 years of age, at 620/100,000/yr. 
Diabetes mellitus was sixth in frequency with an av-
erage of 24.4 deaths/100,000 with a frequency signifi-
cantly higher in women than in men. The frequency 
peaked at 237.6/100,000/yr in those over 60 years of 
age. 
TABLE 1. Death rate for Panama per 100,000: effect of gender and age 
          AGES          
DIAGNOSIS TOTAL  MALE  FEMALE 0-10 10-20  20-25 25-35 35-50 50-60  60+ 
  Total  424.76  486.80  361.57  203.51 50.61 109.94 131.72 205.68 485.15  3126.11 
CV Disease  119.06  131.99  105.89  2.25  2.82  5.44  6.31  32.15  119.00  1193.65 
Cancers 74.71  77.58  71.78  5.40  6.64  7.62  10.71  36.86  135.23  620.18 
Accidents  43.53  71.52  15.02  16.80  23.89  63.13 59.65 49.48 42.44  53.01 
Respiratory Dis-
eases 
 
40.19 
 
44.16 
 
36.14 
 
21.90 
 
1.99 
 
4.72 
 
3.63 
 
10.94 
 
30.37 
 
351.05 
Infectious  31.62  39.48  23.61  24.00 2.32 13.42 31.16 40.56 39.94  108.24 
Diabetes  24.40 19.93  28.95  0.30  0.00  0.36 0.57 7.74  33.70  237.62 
GI  Disorders  17.65 21.55  13.68  2.10  1.16  2.54 2.29 8.92  29.54  146.80 
Urinary Sys Dis-
eases 
 
13.87 
 
16.30 
 
11.39 
 
1.80 
 
1.33 
 
0.73 
 
3.06 
 
5.39 
 
18.31 
 
120.85 
Unclassified 
Symptoms 
 
12.33 
 
13.99 
 
10.63 
 
8.85 
 
0.50 
 
2.90 
 
3.44 
 
2.02 
 
11.23 
 
97.86 
Brain Disorders 
Excl Strokes 
 
 
12.17 
 
 
13.87 
 
 
10.44 
 
 
7.80 
 
 
3.82 
 
 
2.18 
 
 
3.63 
 
 
4.21 
 
 
13.73 
 
 
84.52 
Perinatal  10.94 12.74  9.10  52.04  0.00  0.00 0.00 0.00 0.00  0.00 
Deformities  10.02 11.43  8.59  45.59  1.49  0.36 0.57 0.17 0.00  0.00 
Malnutrition  9.80  9.68  9.93  14.70  2.82  3.63 3.25 3.03 7.07 49.67 
Subcu & Connec-
Tissue Disorders 
 
 
3.63 
 
 
2.56 
 
 
4.71 
 
 
0.00 
 
 
0.66 
 
 
1.45 
 
 
1.72 
 
 
2.69 
 
 
4.58 
 
 
26.32 
Childbirth Prob-
lems 
0.85 0.00  1.72  0.00 
 
0.50  1.45 1.72 1.51 0.00  0.74 
Death rates for the 15 most common causes of death in Panama. The effects of gender and age are shown. The leading causes of death are cardiovas-
cular disease, cancer, and accidents as in much of the world. 
 
In the San Blas, the pattern differed strikingly 
(Table 2). The most common cause of death in the San 
Blas was infections with a frequency of 
80.5/100,000/yr. The frequency of death due to infec-
tions was substantially greater in men Int. J. Med. Sci. 2007, 4 
 
55
(130.1/100,000/yr) than in women (61/100,000/yr). 
The age distribution showed two peaks. An early peak 
in those under 10 years of age was dominated by di-
arrheal illness in the very young. A secondary peak 
occurred in those over 60 years of age. The common 
infections, in addition to diarrhea were tuberculosis, 
malaria, influenza, and HIV. 
In the conditions of interest (Table 2), heart dis-
ease showed a frequency of only 8.3/100,000/yr and 
stroke was even lower, with a frequency of 
3.2/100,000/yr. Cancer and diabetes were equally low 
with a frequency of 3.7/100,000/yr (Table 2).  
Four conditions were predetermined before the 
analysis to be specific targets for effectiveness of fla-
vanols, heart disease, stroke, cancer, and diabetes mel-
litus. The year-by-year findings in Panama and in the 
San Blas for those four conditions are shown in Table 3. 
The stability year-by-year for each diagnosis in Pa-
nama was evident. In the case of cancer, the frequency 
over the five years ranged from 64.2 to 
72.2/100,000/yr with a mean of 68.4±1.60. In San Blas 
during the same interval four of five years showed no 
cancers, and one year showed a peak of 22/100,000/yr 
with a mean of 4.4±4.4 in San Blas: the difference in 
frequency is highly significant (p<0.001). A similar 
pattern exists for ischemic heart disease and stroke, 
each relatively stable in Panama and showing more 
variation in San Blas: The frequency in San Blas for 
both was significantly lower than in mainland Panama 
(p<0.001). In the case of diabetes (Table 3) the same 
consistent difference was found, but the difference was 
smaller: The frequency in San Blas was 39 percent of 
that in Panama. The data are presented by age for these 
4 conditions for the most recent year in which data are 
available, 2004 (Table 4).  
TABLE 2. Death rate for San Blas per 100,000: By Age and Gender 
         AGES             
DIAGNOSIS TOTAL MALE FEMALE  0-10 10-20  20-25  25-35  35-50 50-60  60+ 
Total Regional  192.82  232.06  158.84  174.42  25.25  88.85  120.30  151.71  139.83  928.25 
Infections 80.53  103.14  60.96 62.53  6.31  44.42  75.19  90.38  76.27  336.18 
Respiratory 
Disease 
 
48.78 
 
55.54 
 
42.93 
 
78.98 
 
6.31 
 
12.69 
 
11.28 
 
12.91 
 
19.07 
 
215.76 
GI Disease  11.04  12.89  9.44  1.65  2.10  0.00  11.28  9.68  6.36  75.26 
Malnutrition 10.12  11.90  8.59  4.94  0.00  0.00 11.28  9.68  25.42 45.16 
Brain Disor-
ders, excl 
Strokes 
 
 
9.66 
 
 
12.89 
 
 
6.87 
 
 
4.94 
 
 
8.42 
 
 
6.35 
 
 
3.76 
 
 
3.23 
 
 
6.36 
 
 
50.18 
CV Disease  8.28  9.92  6.87  8.23  0.00  6.35  0.00  3.23  0.00  55.19 
Soft Tissue 
Disorders 
 
6.90 
 
4.96 
 
8.59 
 
0.00 
 
0.00 
 
0.00 
 
0.00 
 
3.23 
 
6.36 
 
65.23 
Diabetes Mel-
litus 
 
3.68 
 
5.95 
 
1.72 
 
0.00 
 
0.00 
 
0.00 
 
0.00 
 
6.46 
 
0.00 
 
30.11 
Accidents 3.68 5.95 1.72 1.65  0.00  12.69  7.52  6.46  0.00  5.02 
Cancers 3.68  2.98  4.29  0.00  2.10  0.00  0.00  6.46  0.00  25.09 
Stroke 3.22  3.97  2.58  0.00  0.00  6.35  6.35  0.00  0.00  30.11 
Perinatal Dis-
eases 
 
3.22 
 
1.98 
 
4.29 
 
11.52 
 
0.00 
 
0.00 
 
0.00 
 
0.00 
 
0.00 
 
0.00 
Death rate for the San Blas Island Chain per 100,000. A similar presentation to Table 1, but focused on the San Blas Islands off the Caribbean Coast. Note 
that cardiovascular disease, cancer, and diabetes are less than 10% of their frequency in the mainland. 
TABLE 3. Age Adjusted Death rate/100,000 for selected causes in Panama 
  YEAR  2000 2001 2002 2003 2004         
         Mean  SD  SEM  n 
IHD*            
Panama    42.1 45.5 42.8 44.6 44.7 43.94  1.43 0.64  5 
San Blas     8.4  2.8  16.8  8.3  7.0  8.7  6.75  3.02  5 
CANCER             
Panama    67.9 64.2 65.7 71.8 72.7 68.36  3.58 1.60  5 
San Blas    0.0  0.0  0.0  22.0  0.0  4.41  9.86  4.41  5 
STROKE            
Panama    40.2 40.4 40.0 42.3 43.8 41.34  1.65 0.74  5 
San  Blas    0.0 0.0 0.0 2.8 0.0 0.55  1.23  0.55 5 
DIABETES            
Panama    21.8 23.2 26.0 25.2 24.4 24.12  1.66 0.74  5 
San Blas    5.6  8.3  11.1  2.8  5.0  6.6  4.33  1.94  5 
*ISH=Ischemic Heart Disease 
Age adjusted death rates per 100,000 over 5 years for the 4 conditions specified in the hypothesis that a very high dietary intake of flavanoids 
might predict. Note the remarkable year-to-year consistency in Panama and the very much lower frequency each year in the San Blas. Int. J. Med. Sci. 2007, 4 
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TABLE 4. Age Adjusted death rate in Panama and Kuna Yala for 2004 
Disease  Total/100,000  25-34 Years  35-44 Years  45-54 Years  55-64 Years  65-74 Years  75 + Years 
IHD          
Panama 44.7  2.5 7.6 19.6  70.8  204.6  1339 
Kuna  Yala  7  0 0 0 0 1 6 
STROKE          
Panama 43.8  0  8.8 27.4  96.2  253.4  1143.1 
Kuna  Yala  0  0 0 0 0 0 0 
CANCER          
Panama 72.7  10.7  29.9  81.9  187.1  503.3  1220 
Kuna  Yala  0  0 0 0 0 0 0 
DIABETES          
 
Panama 
 
24.4 
 
0 
 
0 
 
0 
 
64.1 
 
172.4 
 
586.8 
Kuna  Yala  0  0 1 0 0 2 2 
Age-adjusted death rate in Panama and Kuna Yala for one year, 2004, for the 4 conditions specified in the hypothesis. Note that in Panama each diag-
nosis shows an age-dependent frequency, and that this does not appear in the San Blas. 
 
Four conditions were predetermined before the 
analysis to be specific targets for effectiveness of fla-
vanols, heart disease, stroke, cancer, and diabetes mel-
litus. The year-by-year findings in Panama and in the 
San Blas for those four conditions are shown in Table 3. 
The stability year-by-year for each diagnosis in Pa-
nama was evident. In the case of cancer, the frequency 
over the five years ranged from 64.2 to 
72.2/100,000/yr with a mean of 68.4±1.60. In San Blas 
during the same interval four of five years showed no 
cancers, and one year showed a peak of 22/100,000/yr 
with a mean of 4.4±4.4 in San Blas: the difference in 
frequency is highly significant (p<0.001). A similar 
pattern exists for ischemic heart disease and stroke, 
each relatively stable in Panama and showing more 
variation in San Blas: The frequency in San Blas for 
both was significantly lower than in mainland Panama 
(p<0.001). In the case of diabetes (Table 3) the same 
consistent difference was found, but the difference was 
smaller: The frequency in San Blas was 39 percent of 
that in Panama. The data are presented by age for these 
4 conditions for the most recent year in which data are 
available, 2004 (Table 4).  
TABLE 5. Age distribution in San Blas and mainland Pa-
nama 
 PANAMA  SAN  BLAS 
AGE (Years)  MALE FEMALE MALE  FEMALE 
 
<55 
 
94.1% 93.9% 
 
88% 86.1% 
55-64  3.1% 3.0%  5.8% 6.7% 
65-74  1.8% 1.9%   3.9% 4.7% 
75+  1.0% 1.2%  2.3% 2.5% 
X2 = 11.04. df = 1. P<0.001  
Age-distribution in the San Blas and mainland Panama from the 
census of 2004. Note that there are more individuals over the age of 
55 years among the Kuna in the San Blas than mainland Panama, 
and the frequency is about double during each decade.  
 
Death from trauma was also more frequent in the 
mainland than in the indigenous island location, 
largely reflecting the influence of motor vehicle acci-
dents. In the San Blas, there are neither roads nor 
automobiles, and death from this source was zero. An 
increase in risk in the San Blas was associated with 
perinatal medical problems, infections, and all other 
causes.  
The average age of the Kuna in the islands was 
very much influenced by the mortality in the very 
young, primarily due to diarrhea. As an index of aging, 
we examined the age distribution on the mainland and 
in the islands (Table 5). About 12 percent of both males 
and females in the San Blas were 55 years of age or 
older, about double the 6 percent over that age in the 
Panama mainland (Chi Square = 11.04; p<0.001). 
4.  Discussion 
I n  P a n a m a ,  a s  i n  m u c h  o f  t h e  w e s t e r n  w o r l d ,  
diseases of the circulation are the most common cause 
of death, and cancer is second. The difference in risk of 
death due to these two classes of illness, cancer and 
heart disease, between San Blas and mainland Panama 
was very large. Our original hypothesis was that this 
would be the case if flavanol-rich cocoa and its influ-
ence on nitric oxide synthesis had implications for 
disease pathogenesis, as has been suggested [26]. We 
could explain this extraordinary difference in the risk 
of death by proposing either a better prognosis or a 
lower incidence of these illnesses in San Blas. A re-
duced incidence is the most likely explanation, but 
both a better prognosis and a reduced incidence could 
have a similar explanation. 
The San Blas is the oldest indigenous district in 
the Republic of Panama, having a relatively homoge-
neous population both biologically and ethnically. It 
exhibits one of the highest levels of poverty and eco-
nomic and social exclusion in Panama. The district has 
two hospitals, six health centers, and eleven health 
posts, which do not guarantee access to all levels of 
service. About 40,000 inhabitants are spread over 
forty-nine communities that are widely dispersed 
along the entire Caribbean Coast of Panama. The pro-
file of health of the Kuna residing in the San Blas re-
vealed substantial premature death due to infections: 
Infectious and parasitic diseases made a contribution 
more than 4-fold higher than in the rest of the country. 
The principle reasons were diarrhea, tuberculosis, 
AIDS, influenza, and malaria. Int. J. Med. Sci. 2007, 4 
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One major limitation of our findings involves 
how the diagnosis on the death certificates was estab-
lished. Medical diagnosis follows a well-defined se-
quence in which suspicion is raised from findings ob-
tained from a medical history and physical examina-
tion, followed up with specific tests designed to estab-
lish the diagnosis. In the case of cancer, for example, 
examination of tissue obtained at biopsy is required for 
diagnosis. In the case of heart disease, the diagnosis 
will be established through some combination of 
medical history and physical findings supplemented 
by the results of tests, including x-ray, angiography, 
ultrasound examination, the electrocardiogram, and 
occasionally a biopsy. The availability of the laboratory 
examination probably differs in the San Blas and the 
mainland, but the difference is relative, not absolute. In 
the hospital in Ailigandi, for example, an electrocar-
diogram machine has been available for more than 
fifteen years, and the physicians who staff the hospital 
have worked in Panama City and know how to diag-
nose myocardial infarction. During those fifteen years, 
there have been no cases of myocardial infarction di-
agnosed on Ailigandi (personal communication). Dif-
ferences in the ability to establish a diagnosis may have 
played a larger role in the frequency of cancer diagno-
sis than in the frequency with which heart disease was 
diagnosed, although thousands of Pap smears and 
biopsies are performed annually in the San Blas. In 4 of 
5 years, no cases of cervical cancer were diagnosed. 
Age of the communities at risk is important. As 
both diseases of the circulation and cancer increase in 
frequency with age, death at an earlier age from infec-
tion could have influenced the outcome. In fact, the 
communities living in San Blas are not younger: The 
percentage of Kuna who are over the age of 55 years is 
substantially and statistically higher than in mainland 
communities. Adjustment for age served to enhance 
the difference in the frequency with which disease of 
the circulation or cancer led to death in the San Blas 
versus the mainland.  
Although compatible with the possibility that a 
diet extraordinarily rich in flavonoids contributed to 
the low frequency of circulatory disease and cancer, it 
is obvious that other possibilities exist. These include 
especially different patterns of diagnosis discussed 
above. As another alternative to flavanoid intake to 
account for the difference in disease frequency, the 
possibility that differences in other risk factors con-
tributed cannot be ignored. Unfortunately, the death 
certificates contained none of this information beyond 
age. As the difference was so very large, and the ex-
planation is so important, follow-up population-based 
studies will be important to examine these risk factors 
prospectively. Until such data are available, the results 
of this study should be interpreted with great caution.  
Other lifestyle variables may play a role in health 
outcomes by region. Stress is commonly suspected to 
be lower on the islands than on the mainland (com-
monly by people who have actually never visited the 
islands). We have assessed stress in the Panamanian 
mainland and islands, and there is a difference favor-
ing the islands, but it is small [30]. Another possible 
difference is diet. We and others have examined the 
diet in the San Blas and Kuna living in the Panamanian 
mainland carefully and although several differences 
are noted, the most remarkable is cocoa intake [14]. 
However, we have no information on diet and the 
frequency of other risk factors in non-Kuna living in 
the Panamanian mainland. Obtaining this information 
should have a high priority. There is very probably less 
exposure to pollutants in the water and in the air in the 
San Blas compared to the mainland, especially for 
those inhabitants that live in the city. Tobacco use by 
Kuna is limited both in the indigenous island site and 
the mainland. 
Other variables may influence age-specific death 
rates by region. One common practice among the Kuna 
involves working on the mainland on a job for a salary 
for many years, followed by retirement to the San Blas 
indigenous island life where life is less stressful, and 
less expensive. To the extent that occurred, and if 
twenty or thirty years of life on the Panamanian 
mainland do not lead to changes that cannot be re-
versed by return to the island, differences between the 
two locations may have been underestimated. 
If indeed they do protect, how might the flavon-
oids provide protection? Our hypothesis was that in 
the case of vascular disease the responsible pathway 
could involve stimulation of nitric oxide synthesis and 
thereby reversal of endothelial dysfunction [23, 24]. 
Alternative possibilities, also possibly related to nitric 
oxide, include improvements in insulin sensitivity [25], 
improvements in platelet function [15], inhibition of 
LDL oxidation [28], and an increase in plasma HDL 
cholesterol concentration [29]. The influence of nitric 
oxide on insulin sensitivity would also provide an ex-
planation for the difference in the frequency of diabe-
tes mellitus [25] in the San Blas and the mainland [1]. 
In addition, a role in carcinogenesis may be hypothe-
sized through nitric oxide cell-to-cell communication 
[1].  
Death certificates provide core information, es-
pecially important at the national level [31, 32]. The 
findings can be misleading. For example, if someone 
dies with both cancer and diabetes, the cancer is far 
more likely to be recorded [33]. This problem should 
not have influenced our findings, as heart attack, 
stroke, and cancer are likely to have been chosen from 
among a range of possible diagnoses, and there is no 
reason why the pattern should differ on the mainland 
and in the San Blas.   
Despite the other possible explanations for the 
large differences in deaths from cardiovascular disease 
and cancer with an array of possible confounding fac-
tors, it is improbable that these could abolish the car-
diovascular and cancer protective effect observed 
among the San Blas Kuna as compared to the mainland. 
Although the findings are compatible with effect of the 
flavanol-rich cocoa on health, clearly a large number of 
alternative possibilities exist involving diet, physical 
activity, stress and genetic factors. An observational 
study of this kind cannot prove causality. Indeed, only Int. J. Med. Sci. 2007, 4 
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a randomized, controlled clinical trial in which all of 
these factors can be controlled will lead to a definitive 
conclusion. All of these issues can be addressed, but 
that will take time and substantial resources. 
Acknowledgments 
This study was funded in part by the Instituto 
Commemorativo Gorgas de Estudios de la Salud and 
the M&M/Mars Company. None of these funding 
sources participated in the collection of the data or its 
analysis.  
Conflicts of interest 
The authors have declared that no conflict of in-
terest exists. 
References 
1.  Middleton E Jr, Kandaswami C, Theoharides TC. The effects of 
plant flavonoids on mammalian cells: Implications for inflam-
mation, heart disease and cancer. Phamacol Rev 2000; 
52(4):673-751. 
2.  St Leger AS, Cochrane AL, Moore F. Factors associated with 
cardiac mortality in developed countries with particular refer-
ence to the consumption of wine. Lancet 1979; 1:1017-1020. 
3.  Hertog MGL, Feskens EJM, Hollman PCH, et al. Dietary anti-
oxidant flavonoids and risk of coronary heart disease: the 
Zutphen Elderly Study. Lancet 1993; 342:1007-1011. 
4.  Hollman PCH, Katan MB. Health effects and bioavailability of 
dietary flavonols. Free Rad Res 1999; 31 (Suppl Dec):S75-S80. 
5.  Arts ICW, Jacobs DRJ, Harnack LJ, et al. Dietary catechins in 
relation to coronary heart disease death among postmeno-
pausal women. Epidemiology 2001; 12:668-675. 
6.  Arts ICW, Hollman PCH, Feskens EJM, et al. Catechin intake 
might explain the inverse relation between tea consumption 
and ischemic heart disease: the Zutphen Elderly Study. Am J 
Clin Nutr 2001; 74:227-232. 
7.  Kris-Etherton PM, Keen CL. Evidence that antioxidant flav-
nonoids in tea and cocoa are beneficial for cardiovascular 
health. Curr Opin Lipid 2002; 13:14-49. 
8.  Ross JA, Kasum CM. Dietary flavonoids: bioavailability, 
metabolic effects, and safety. Annu Rev Nutr 2002; 22:19-34. 
9.  Peters U, Poole C, Arab L. Does tea affect cardiovascular dis-
ease? A meta-analysis. Am J Epidemiol 2001;154:495-503. 
10.  Maron DJ. Flavonoids for reduction of atherosclerotic risk. 
Curr Atheroscl Rep 2004; 6:73-78. 
11.  Lagiou P, Samoli E, Lagiou A, et al. Intake of specific flavonoid 
classes and coronary heart disease-a cause control study in 
Greece. Eur J Clin Nutr 2004; 58:1643-1648. 
12.  Mennen LI, Sapinyho D, deBree A, et al. Consumption of foods 
rich in flavonoids is related to a decreased cardiovascular risk 
in apparently healthy French women. J Nutr 2004; 134:923-926.   
13.  Arts ICW, Hollman PCH. Polyphenols and disease risk in epi-
demiologic studies. Am J Clin Nutr 2005; 81 (Suppl 1): 
S317-S325. 
14.  McCullough MJ, Chevaux K, Jackson L, Preston M, Martinez G, 
Schmitz HH, Coletti C, Campos H, and Hollenberg NK. Hy-
pertension, the Kuna, and the epidemiology of flavanols. J 
Cardiovasc Pharmacol 2006; 47 (Suppl 2): S103-S109. 
15.  Buijsse B, Feskens EJM, Kok FJ, et al. Cocoa intake, blood 
pressure, and cardiovascular mortality. The Zutphen Elderly 
Study. Arch Intern Med 2006; 166:411-417 
16.  Gu L, Kelm MA, Hammerstone JF, et al. Concentrations of 
proanthocyanidins in common foods and estimates of normal 
consumption. J Nutr 2004; 134:613-617. 
17.  Hammerstone JF, Lazarus SA, Schmitz HH. Procyanidin con-
tent and variation in some commonly consumed foods. J Nutr 
2000; 130 (Suppl 8): S2086-S2092. 
18.  Fisher NDL and Hollenberg NK. Flavanols for cardiovascular 
health: the science behind the sweetness. J Hyperten 2005; 
23:1453-1459. 
19.  Kean BH. The BP of the Kuna Indians. Am J Trop Med Hyg 
1944; 24:341-343. 
20.  Hollenberg NK, Martinez G, McCullough M, et al. Aging, ac-
culturation, salt intake, and hypertension. Hypertension 1997; 
29:171-176. 
21.  Hollenberg NK, Rivera A, Meinking T, et al. Age, renal perfu-
sion, and function in island-dwelling indigenous Kuna Amer-
inds of Panama. Nephron 1999; 82:131-138. 
22.  Chevaux KA Jackson L, Villar ME, et al. Proximate mineral and 
procyandin content of certain foods and beverages consumed 
by Kuna Amerinds of Panama. J Food Compos & Analysis 
2001; 14:553-563. 
23.  Fisher ND, Hughes M, Gerhard-Herman M, et al. Flavanol-rich 
cocoa induces nitric-oxide-dependent vasodilation in healthy 
humans. J Hypertension 2003; 21:2281-2286. 
24.  Heiss C, Dejam A, Kleinbongard P, et al. Vascular effects of 
cocoa rich in flavan-3-ols. JAMA 2003; 290:1030-1031. 
25.  Grassi D, Necozlone S, Lippi C, et al. Cocoa reduces blood 
pressure and insulin resistance and improves endothe-
lium-dependent vasodilation in hypertensives. Hypertension 
2005; 46:398-405. 
26.  Haegeli L, Quitzau K, and Luscher TF. From endothelial dys-
function to clinical events. Concept and update on the 
ENCORE trials. Eur Heart J 2001; 3 (Suppl B): S12-S19. 
27.  Holt RR, Schramm DD, Keen CL, et al. Chocolate consumption 
and platelet function. JAMA 2002; 287:2212-2213. 
28.  Osakabe N, Baba S, Yasuda A, et al. Daily cocoa intake reduces 
the susceptibility of low-density lipoprotein to oxidation as 
demonstrated in healthy human volunteers. Free Radic Res 
2001; 34:93-99. 
29.  Mursu J, Voutilainen S, Nurmi T, et al. Dark chocolate con-
sumption increases HDL cholesterol concentration and choco-
late fatty acids may inhibit lipid peroxidation in healthy hu-
mans. Free Radic Biol Med 2004; 37:1351-1359. 
30.  Hollenberg NK, Mohres E, Meinking T, et al. Stress and blood 
pressure in Kuna Amerinds. J Hypertension 2005; 7:714-720. 
31.  Kassai B, Gueyffier F, Boissel J-P, et al. Absolute benefit, num-
ber needed to treat and gain in life expectancy: which efficacy 
indices for measuring the treatment benefit? J Clin Epidemiol-
ogy 2003; 56:977-982. 
32.  Gueyffier F, Wright J. The lower the better: Does simplicity 
lead to absurdity? J Hypertension 2006; 24:431-433. 
33.  McEwen LN, Kim C, Haan M, et al. Diabetes reporting as a 
cause of death. Diabetes Care 2006; 29:247-253. 
 